{"id":"NCT00553267","sponsor":"Boehringer Ingelheim","briefTitle":"Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension","officialTitle":"An Eight-week Randomised, Double-blind Study to Compare the Fixed-dose Combination of Telmisartan 40mg + Amlodipine 10mg Versus Telmisartan 80mg + Amlodipine 10mg Versus Amlodipine 10mg Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With Amlodipine 10mg Monotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-11","primaryCompletion":"2008-10","completion":null,"firstPosted":"2007-11-05","resultsPosted":"2009-12-22","lastUpdate":"2014-02-13"},"enrollment":947,"design":{"allocation":null,"model":"PARALLEL","masking":null,"primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"fixed dose combination of telmisartan+amlodipine","otherNames":[]},{"type":"DRUG","name":"amlodipine","otherNames":[]}],"arms":[],"summary":"The primary objective of this trial is to demonstrate that the fixed dose combination of telmisartan 40mg + amlodipine 10mg (T40/A10) or the fixed dose combination of telmisartan 80mg + amlodipine 10mg (T80/A10) is superior in reducing blood pressure at eight weeks compared with amlodipine 10mg monotherapy (A10) in patients who fail to respond to six weeks treatment with A10.","primaryOutcome":{"measure":"Change From Baseline in Trough Seated Diastolic Blood Pressure","timeFrame":"Baseline and end of study (8 weeks or last value on treatment)","effectByArm":[{"arm":"Amlodipine 10mg","deltaMin":-6.48,"sd":0.45},{"arm":"Telmisartan 40mg and Amlodipine 10mg","deltaMin":-9.24,"sd":0.45},{"arm":"Telmisartan 80mg and Amlodipine 10mg","deltaMin":-9.33,"sd":0.45}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":18},"locations":{"siteCount":97,"countries":["Australia","Austria","Bulgaria","Czechia","Ireland","Italy","New Zealand","Russia","Slovakia","Spain","Switzerland","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1},"commonTop":["Peripheral oedema"]}}